Guidelines : Osteoporosis

Detail

Condition :

Osteoporosis

Keywords :

bisphosphonates, postmenopausal osteoporosis, bone density, abaloparatide, romosozumab, teriparatide

BNF Codes :

Committee Recommendations

Date

Committee Name

Narrative

Traffic Light Status

05 March 2025

Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed an updated Osteoporosis pathway for specialist (high cost) treatments.

Please note that algorithm 1 in the Osteoporosis Guidelines has not been updated.

N/A

02 June 2021

Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Osteoporosis guidelines have been reviewed and updated.

The guidelines are supported by two algorithms which have been extracted from the guideline and provided as separate documents (below) for ease of use:
Algorithm 1 - Treatment Pathway for adults
Algorithm 2 - Review of Long-term Bisphosphonate Therapy

Calcium & vitamin D:
AdcalD3/ AccreteD3 twice daily formulations are the preferred calcium and vitamin D supplements.
Accrete D3 One a Day, Calci-D chewable tablets or theiCal-D3 chewable tablets are once daily options for patients with compliance issues.

N/A